[1]
“Treatment of diabetes in elderly of 65 years. Review and utility of glp-1 in this group of patients”, Eur.J.Health.res, vol. 2, no. 1, pp. 5–14, Apr. 2016, doi: 10.30552/ejhr.v2i1.12.